Granulocyte contamination dramatically inhibits spot formation in AIDS virus-specific ELISpot assays: Analysis and strategies to ameliorate

Journal of Immunological Methods

Volumn 297, Issue 1-2, 2005, Pages 177-186

  De Rose, Robert ^a   Taylor, Erin L ^a   Law, Mathew G ^b   Van Der Meide, Peter H ^c   Kent, Stephen J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

ELISpot; Granulocytes; PBMC; SIV

Indexed keywords

DNA VACCINE; GAMMA INTERFERON ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; RECOMBINANT VACCINE;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; GRANULOCYTE; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOHISTOCHEMISTRY; MACACA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RELIABILITY; SIMIAN IMMUNODEFICIENCY VIRUS;

AIDS VIRUS; MACACA; MACACA NEMESTRINA; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 15244341448     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.12.009     Document Type: Article

References (18)

1. R.R. Amara, F. Villinger, J.D. Altman, S.L. Lydy, S. O'Neil, S. Staprans, D. Montefiori, Y. Xu, J. Herndon, L. Wyatt, M. Candido, N. Kozyr, P. Earl, J. Smith, H. Ma, B. Grimm, M. Hulsey, J. Miller, H. McClure, J. McNicholl, B. Moss, and H.L. Robinson Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 292 2001 69
2. C.C. Czerkinsky, L.A. Nilsson, H. Nygren, O. Ouchterlony, and A. Tarkowski A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells J. Immunol. Methods 65 1983 109
3. C. Czerkinsky, G. Andersson, H.P. Ekre, L.A. Nilsson, L. Klareskog, and O. Ouchterlony Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells J. Immunol. Methods 110 1988 29
4. C.J. Dale, X.S. Liu, R. De Rose, D.F. Purcell, J. Anderson, Y. Xu, G.R. Leggatt, I.H. Frazer, and S.J. Kent Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques Virology 301 2002 176
5. C.J. Dale, R. De Rose, I. Stratov, S. Chea, D.C. Montefiori, S. Thomson, I.A. Ramshaw, B.E. Coupar, D.B. Boyle, M. Law, and S.J. Kent Efficacy of DNA and fowl pox virus priming/boosting vaccines for simian/human immunodeficiency virus J. Virol. 78 2004 13819
6. C.J. Dale, R. De Rose, K.M. Wilson, H.A. Croom, S. Thomson, B.E. Coupar, A. Ramsay, D.F. Purcell, R. Ffrench, M. Law, S. Emery, D.A. Cooper, I.A. Ramshaw, D.B. Boyle, and S.J. Kent Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowl pox virus vaccines co-expressing IFNgamma or IL-12 Vaccine 23 2004 188
7. S.E. Gloster, P. Newton, D. Cornforth, J.D. Lifson, I. Williams, G.M. Shaw, and P. Borrow Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection Aids 18 2004 749
8. J.M. Harouse, A. Gettie, T. Eshetu, R.C. Tan, R. Bohm, J. Blanchard, G. Baskin, and C. Cheng-Mayer Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3) J. Virol. 75 2001 1990
9. A. Kapp, R. Gillitzer, H. Kirchner, and E. Schopf Decreased production of interferon in whole blood cultures derived from patients with psoriasis J. Invest. Dermatol. 90 1988 511
10. A.C. Karlsson, J.N. Martin, S.R. Younger, B.M. Bredt, L. Epling, R. Ronquillo, A. Varma, S.G. Deeks, J.M. McCune, D.F. Nixon, and E. Sinclair Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells J. Immunol. Methods 283 2003 141
11. S.J. Kent, A. Zhao, S. Best, J.D. Chandler, D.B. Boyle, and I.A. Ramshaw Enhanced T cell immunogenicity and protective efficacy from a HIV-1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowl pox virus J. Virol. 72 1998 10180
12. A. Kumar, W. Weiss, J.A. Tine, S.L. Hoffman, and W.O. Rogers ELISPOT assay for detection of peptide specific interferon-gamma secreting cells in rhesus macaques J. Immunol. Methods 247 2001 49
13. H.T. Maecker, H.S. Dunn, M.A. Suni, E. Khatamzas, C.J. Pitcher, T. Bunde, N. Persaud, W. Trigona, T.M. Fu, E. Sinclair, B.M. Bredt, J.M. McCune, V.C. Maino, F. Kern, and L.J. Picker Use of overlapping peptide mixtures as antigens for cytokine flow cytometry J. Immunol. Methods 255 2001 27
14. N.D. Russell, M.G. Hudgens, R. Ha, C. Havenar-Daughton, and M.J. McElrath Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity J. Infect. Dis. 187 2003 226
15. J. Schmielau, and O.J. Finn Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients Cancer Res. 61 2001 4756
16. A. Schmittel, U. Keilholz, S. Bauer, U. Kuhne, S. Stevanovic, E. Thiel, and C. Scheibenbogen Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteins J. Immunol. Methods 247 2001 17
17. S. Tanguay, and J.J. Killion Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells Lymphokine Cytokine Res. 13 1994 259
18. Z.F. Vasconcelos, B.M. Santos, E.S. Costa, M. Lima, D.G. Tabak, L.F. Bouzas, W.M. Azevedo, M.A. Barcinski, and A. Bonomo T-lymphocyte function from peripheral blood stem-cell donors is inhibited by activated granulocytes Cytotherapy 5 2003 336